Glenmark to launch fixed‐dose drug for type-2 Diabetes in India

Bilgin

Global Mod
Global Mod
Glenmark to launch fixed‐dose drug for type-2 Diabetes in India Glenmark to launch Teneligliptin + Pioglitazone fixed‐dose drug for type-2 Diabetes in India
 
Üst